SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (7035)4/14/1998 10:48:00 PM
From: VLAD  Read Replies (2) | Respond to of 23519
 
Bradpalm1,

Did you cover that large short position yet?
Today was your best opportunity.

VLAD



To: Bradpalm1 who wrote (7035)4/14/1998 10:50:00 PM
From: E'Lane  Respond to of 23519
 
Bradpalm

<<The 1999 PDR will be published containing Viagra's complete prescribing information in all its glory.>>

Yeah, but I bet the pictures won't be near as interesting! <g> JOKING, ok?

I realized the book was published prior to Viagra's approval. I still think it was a plus for Vivus.

Thanks for your reply,
E'Lane



To: Bradpalm1 who wrote (7035)4/15/1998 7:21:00 AM
From: James Baker  Respond to of 23519
 
*<<<< The European rollout of the drug should also happen shortly since MCA
approval was concurrent with FDA approval of Viagra.

Bradpalm1>>>>>>>>

Brad,
where did you get this news? I don't think that BigK has even mentioned this. And why should it be "concurrent" since these are independently functioning bodies governing different countries?
Jim


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News